News & Insights

Cases & Deals

April 20, 2017

K&S Team Holds Jury to Less Than One-Tenth of Plaintiff’s Requested Damages in Generic Paroxetine-Suicide Case


In July 2012, Plaintiff Wendy Dolin filed a lawsuit against GlaxoSmithKline (“GSK”) alleging that her husband, Stewart Dolin, took his own life as a result of developing paroxetine-induced akathisia (psychomotor restlessness). Days before his death, Mr. Dolin allegedly began taking paroxetine manufactured by Mylan Pharmaceuticals, Inc., a generic form of GSK’s antidepressant Paxil. Plaintiff alleged that GSK failed to warn of a possible association between paroxetine and an increased risk of suicidal behavior in adult patients over the age of twenty-four, and that Mr. Dolin’s use of paroxetine caused him to commit suicide. Following a six-week trial, and after three days of deliberations, an Illinois federal court jury awarded plaintiff Wendy Dolin $3 million in wrongful death and survival damages, a fraction of the $39 million award her counsel had requested.